ACB - Aurora Cannabis Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
+0.0232 (+4.51%)
As of 12:36PM EDT. Market open.
Stock chart is not supported by your current browser
Previous Close0.5143
Bid0.5361 x 1100
Ask0.5379 x 1300
Day's Range0.5031 - 0.5393
52 Week Range0.4900 - 1.9400
Avg. Volume3,445,950
Market Cap183.281M
Beta (5Y Monthly)3.00
PE Ratio (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Baystreet

    Stocks in play: Aurora Cannabis Inc

    Said its Aurora Europe GmbH subsidiary and Ethypharm have once again been selected by the French General ...

  • Motley Fool

    The Most Likely Scenario for Aurora Cannabis Stock Doesn't Look Good

    Aurora Cannabis (NASDAQ: ACB) has been struggling for years. The stock is trading down to well under $1 per share, and another reverse stock split is inevitable for the company. Aurora Cannabis' stock price fell 96% over the past three years.

  • The Motley Fool

    2 TSX Stocks to Buy This Month and 1 to Avoid

    Investors looking to add quality growth stocks to their equity portfolio can consider buying Well Health right now. The post 2 TSX Stocks to Buy This Month and 1 to Avoid appeared first on The Motley Fool Canada.

  • Motley Fool

    Better Buy: Aurora Cannabis vs. Trulieve Cannabis

    One was once a favorite among cannabis investors, but the other could become the top cannabis contender.

  • The Motley Fool

    What’s Happening With Cannabis Stocks in May 2023?

    Cannabis stocks were up this week, as the market began to turn, but how long will it last, and is more growth coming? The post What’s Happening With Cannabis Stocks in May 2023? appeared first on The Motley Fool Canada.

  • The Motley Fool

    Aurora Cannabis: Time to Light Up Your Portfolio?

    Here's my take on whether Aurora Cannabis (TSX:ACB) is worth adding to a growth portfolio right now, given its growth prospects and fundamentals. The post Aurora Cannabis: Time to Light Up Your Portfolio? appeared first on The Motley Fool Canada.

  • Motley Fool

    This Troubled Stock Might Go Up in Smoke

    It's been roughly five years since Canada legalized cannabis, and it's been an unpleasant ride for investors in Aurora Cannabis (NASDAQ: ACB), one of Canada's leading growers and operators. The company became a penny stock after surging to over $120 per share in 2018. While some may hope for a tremendous comeback story, sometimes a business model just isn't good.

  • The Motley Fool

    1 Marijuana Stock I’d Buy Over Aurora Cannabis

    Explore a promising marijuana stock that outshines Aurora Cannabis. Unveil the investment opportunity to boost your cannabis portfolio. The post 1 Marijuana Stock I’d Buy Over Aurora Cannabis appeared first on The Motley Fool Canada.

  • Motley Fool

    Better Growth Stock: Aurora Cannabis vs. Tilray Brands

    Marijuana stocks have fallen out of favor in the last two years. The Canadian producers Aurora Cannabis (NASDAQ: ACB) and Tilray Brands (NASDAQ: TLRY) are two of the most popular marijuana companies. Aurora Cannabis has been investors' favorite among pot stocks for a while.

  • Baystreet

    Stocks in play: Aurora Cannabis

    Today announced a fresh lineup of innovative products. Coming soon to patients at Aurora Medical and ...

  • Motley Fool

    How Aurora Cannabis, Curaleaf, and SNDL Stack Up on 420 Day 2023

    April 20th has a special significance for the cannabis industry. Three of those companies have especially attracted investors' attention in recent years -- Aurora Cannabis (NASDAQ: ACB), Curaleaf Holdings (OTC: CURLF), and SNDL (NASDAQ: SNDL) (formerly known as Sundial Growers). Aurora Cannabis is the worst of the group, with its share price plunging more than 80%.

  • Motley Fool

    3 Former High-Flying Stocks Down 92% to 99% That Billionaire Investors Can't Stop Buying

    Despite losing most of their value, these former Wall Street darlings have been popular buys among billionaire money managers.

  • Motley Fool

    Which Canadian Cannabis Company Will Be the Next Takeover Target?

    The Canadian government's decision to license over 1,000 cannabis producers, along with its inability to rein in black market operators, has been an unmitigated disaster for the country's top legal cultivators. Despite billions of dollars being spent on state-of-the-art cultivation facilities, brick-and-mortar retail outlets, and virtual storefronts, Canada's largest cannabis companies have been losing money at an alarming rate due to a vast oversupply of product in the country. In turn, profit margins have cratered across the industry, spurring some notable cannabis companies like Aurora Cannabis (NASDAQ: ACB), SNDL, and Tilray Brands to diversify into non-cannabis businesses like alcohol and vegetables in an effort to become cash-flow-positive.

  • The Motley Fool

    Are Cannabis Stocks a Good Buy in April 2023?

    Here's why cannabis stocks such as Aurora Cannabis and Canopy Growth remain high-risk bets for TSX investors. The post Are Cannabis Stocks a Good Buy in April 2023? appeared first on The Motley Fool Canada.

  • Motley Fool

    Better Buy: Aurora Cannabis vs. Green Thumb Industries

    Marijuana stocks have performed poorly over the last two years. Cannabis analytics firm BDSA estimates that global cannabis sales will reach $57 billion by 2026, a 13% annual growth forecast from $30 billion in 2021, with bulk of this growth expected to be driven by the Canadian and American markets. Investment opportunities seem lucrative, and investors with a higher risk appetite might stand to profit handsomely in the long run in this volatile industry.

  • Motley Fool

    Why Aurora Cannabis Stock Is Slumping Today

    Canadian marijuana company Aurora Cannabis (NASDAQ: ACB) is having another bad day. The pot seller's shares were down by a noteworthy 4.34% on moderate volume as of 2:05 p.m. ET on Monday. Since the start of the year, Aurora's stock has now shed 27.5% of its value, and the share price has fallen well below the Nasdaq's $1 bid requirement, triggering a noncompliance notice from the exchange last month.

  • Market Exclusive

    Weekly Roundup on the Cannabis Sector & Psychedelic Sector

    Key Takeaways; Cannabis Sector Aurora announced the repurchase of convertible senior notes worth approximately $47 million, saving the company $2.6 million in annualized interest payments. Jushi Holdings reported preliminary Q4 and record full year 2022 financial results. Curaleaf announced $20 million acquisition in Key Takeaways; Psychedelic Sector Awakn’s proprietary treatment protocol for alcohol use disorder […] The post Weekly Roundup on the Cannabis Sector & Psychedelic Sector appeared fi

  • Motley Fool

    Don't Buy the Hype: Aurora Cannabis' Transformation Hasn't Worked

    Restructuring and changes in strategy are moves that businesses often deploy when they're facing challenges and headwinds. While Aurora Cannabis (NASDAQ: ACB) has been slashing costs and changing its operations in recent years, the company isn't out of the woods by any stretch. Among the biggest moves that Aurora has made in recent years has been to shift its business more toward medical marijuana.

  • Motley Fool

    2 Reasons to Buy Aurora Cannabis and 1 Reason to Sell It

    Aurora Cannabis (NASDAQ: ACB) is one of the few Canadian cannabis retailers that is still seeing revenue growth, despite price compression and illegal sales negatively impacting the industry. The company is still losing money, but it appears to be edging its way toward profitability. Aurora's path to success includes branching out to international markets while focusing more on medical marijuana sales at home.

  • Motley Fool

    Why Pot Stocks Are Glowing Green Today

    With fears of economic turbulence receding, Aurora Cannabis, Canopy Growth, and Organigram rebounded from their Monday declines.

  • Motley Fool

    Here's How Aurora Cannabis Finally Posted an Adjusted EBITDA Profit

    Aurora Cannabis (NASDAQ: ACB) hit a long-awaited milestone in its most recent earnings results: adjusted earnings before interest, taxes, depreciation, and amortization (EBITDA) profitability. Here's a closer look at how Aurora achieved an adjusted EBITDA profit, and whether that should impact your decision to buy the stock or not. Since it's a non-GAAP (adjusted) number, a company can make adjustments to that number that it otherwise wouldn't be able to make to net income.

  • Motley Fool

    1 Trend for Cannabis Investors to Watch for in 2023

    The cannabis industry in Canada hasn't been in good shape for some time. Growth is almost nonexistent, profits are elusive, and stock prices of marijuana producers have been nosediving. What's particularly telling are the moves of two of the industry's leaders, Aurora Cannabis (NASDAQ: ACB) and Canopy Growth (NASDAQ: CGC).

  • Motley Fool

    3 Cannabis Stocks to Buy and Hold for the Next 10 Years

    One sector that's undoubtedly gone from bubble territory to flat-out deflated is cannabis. Many producers saw valuations skyrocket upon the federal legalization of cannabis in Canada in late 2018. U.S.-based multi-state operators (MSOs) like Curaleaf (OTC: CURLF) have certainly had a rough go over the past two years.

  • The Motley Fool

    What’s Next for Aurora Cannabis Stock?

    Aurora Cannabis stock is down 99% from all-time highs. Is ACB stock a buy, sell, or hold in March 2023? The post What’s Next for Aurora Cannabis Stock? appeared first on The Motley Fool Canada.

  • Motley Fool

    Here's the Single Best Argument for Buying Aurora Cannabis Stock Right Now

    Suppose you bought $10,000 of Aurora Cannabis (NASDAQ: ACB) stock five years ago and held onto those shares. With that abysmal performance, you might think making a case for investing in Aurora Cannabis today would be an exercise in futility. If these four words are true, buying the heavily beaten-down marijuana stock could pay off nicely.